Testing effectiveness (Phase 2)Study completedNCT00738829
What this trial is testing
Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL
Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Arbeitsgemeinschaft medikamentoese Tumortherapie 45